Altinmakas Emre, Perrier Nancy D, Grubbs Elizabeth G, Lee Jeffrey E, Prieto Victor G, Ng Chaan S
Department of Radiology, Koç School of Medicine, Koç University, Istanbul, Turkey.
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Acta Radiol. 2020 Aug;61(8):1080-1086. doi: 10.1177/0284185119889568. Epub 2019 Dec 2.
Differentiation of adenoma and pheochromocytoma on computed tomography (CT) may be problematic.
To investigate if adenoma and pheochromocytoma can be differentiated with adrenal CT.
A total of 147 pathologically proven adrenal masses (119 adenomas, 28 pheochromocytomas) that had undergone adrenal CT were retrospectively evaluated. Lesion attenuation on unenhanced phase (UEP), portal phase (PP), 15-min delayed phase (DP), absolute/relative percentage enhancement wash-out (APEW/RPEW), and qualitative features were recorded. Student's t-test for parametric data, Mann-Whitney U test for non-parametric data, and Fisher's exact test for categorical data were used. Diagnostic performance of CT attenuation was assessed by area under the curve (AUC) of the receiver operating characteristics.
APEW of adenomas was not significantly different from pheochromocytomas; 68.4% and 59% (=0.284). Adenomas had significantly higher RPEW; 57.3% vs. 37.4% (=0.004). Of pheochromocytomas, 50% met APEW >60% or RPEW >40% criteria, and therefore were misclassified as adenoma on wash-out CT. Of those, 80% (4/5) were < 3 cm. UEP, PP, and DP attenuations of pheochromocytomas were significantly higher than adenomas; however, they were overlapping. AUC for UEP, PP, and DP was 0.906, 0.784, and 0.926, respectively. Larger pheochromocytomas were more likely to contain necrosis compared to smaller pheochromocytomas and adenomas; 41.6% vs. 12.5% vs. 3%. Homogeneous enhancement was seen in 25% of pheochromocytomas and 49% of adenomas (=0.018). No significant difference was found in terms of lesion borders and presence of fat/calcification (>0.05).
A considerable percentage of pheochromocytomas, especially smaller ones, demonstrate adenoma-like wash-out on CT. Heterogeneous enhancement, higher attenuation, and necrosis are more suggestive of pheochromocytoma.
在计算机断层扫描(CT)上鉴别腺瘤和嗜铬细胞瘤可能存在困难。
研究肾上腺CT能否鉴别腺瘤和嗜铬细胞瘤。
回顾性评估147例经病理证实的肾上腺肿块(119例腺瘤,28例嗜铬细胞瘤),这些肿块均已接受肾上腺CT检查。记录平扫期(UEP)、门静脉期(PP)、15分钟延迟期(DP)的病灶衰减值、绝对/相对百分比强化洗脱(APEW/RPEW)以及定性特征。对参数数据采用学生t检验,对非参数数据采用曼-惠特尼U检验,对分类数据采用费舍尔精确检验。通过受试者操作特征曲线下面积(AUC)评估CT衰减的诊断性能。
腺瘤的APEW与嗜铬细胞瘤无显著差异;分别为68.4%和59%(P=0.284)。腺瘤的RPEW显著更高;分别为57.3%和37.4%(P=0.004)。在嗜铬细胞瘤中,50%符合APEW>60%或RPEW>40%的标准,因此在CT洗脱时被误诊为腺瘤。其中,80%(4/5)直径<3 cm。嗜铬细胞瘤的UEP、PP和DP衰减值显著高于腺瘤;然而,它们存在重叠。UEP、PP和DP的AUC分别为0.906、0.784和0.926。与较小的嗜铬细胞瘤和腺瘤相比,较大的嗜铬细胞瘤更易出现坏死;分别为41.6%、12.5%和3%。25%的嗜铬细胞瘤和49%的腺瘤表现为均匀强化(P=0.018)。在病灶边界以及脂肪/钙化的存在方面未发现显著差异(P>0.05)。
相当比例的嗜铬细胞瘤,尤其是较小的嗜铬细胞瘤,在CT上表现出类似腺瘤的洗脱特征。不均匀强化、更高的衰减值和坏死更提示为嗜铬细胞瘤。